Cargando…
DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage
Oncolytic virotherapy is a promising therapeutic strategy that uses replication-competent viruses to selectively destroy malignancies. However, the therapeutic effect of certain oncolytic viruses (OVs) varies among cancer patients. Thus, it is necessary to overcome resistance to OVs through rational...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194050/ https://www.ncbi.nlm.nih.gov/pubmed/30337542 http://dx.doi.org/10.1038/s41467-018-06771-4 |
_version_ | 1783364156573876224 |
---|---|
author | Xiao, Xiao Liang, Jiankai Huang, Chunlong Li, Kai Xing, Fan Zhu, Wenbo Lin, Ziqing Xu, Wencang Wu, Guangen Zhang, Jifu Lin, Xi Tan, Yaqian Cai, Jing Hu, Jun Chen, Xueqin Huang, Youwei Qin, Zixi Qiu, Pengxin Su, Xingwen Chen, Lijun Lin, Yuan Zhang, Haipeng Yan, Guangmei |
author_facet | Xiao, Xiao Liang, Jiankai Huang, Chunlong Li, Kai Xing, Fan Zhu, Wenbo Lin, Ziqing Xu, Wencang Wu, Guangen Zhang, Jifu Lin, Xi Tan, Yaqian Cai, Jing Hu, Jun Chen, Xueqin Huang, Youwei Qin, Zixi Qiu, Pengxin Su, Xingwen Chen, Lijun Lin, Yuan Zhang, Haipeng Yan, Guangmei |
author_sort | Xiao, Xiao |
collection | PubMed |
description | Oncolytic virotherapy is a promising therapeutic strategy that uses replication-competent viruses to selectively destroy malignancies. However, the therapeutic effect of certain oncolytic viruses (OVs) varies among cancer patients. Thus, it is necessary to overcome resistance to OVs through rationally designed combination strategies. Here, through an anticancer drug screening, we show that DNA-dependent protein kinase (DNA-PK) inhibition sensitizes cancer cells to OV M1 and improves therapeutic effects in refractory cancer models in vivo and in patient tumour samples. Infection of M1 virus triggers the transcription of interferons (IFNs) and the activation of the antiviral response, which can be abolished by pretreatment of DNA-PK inhibitor (DNA-PKI), resulting in selectively enhanced replication of OV M1 within malignancies. Furthermore, DNA-PK inhibition promotes the DNA damage response induced by M1 virus, leading to increased tumour cell apoptosis. Together, our study identifies the combination of DNA-PKI and OV M1 as a potential treatment for cancers. |
format | Online Article Text |
id | pubmed-6194050 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-61940502018-10-22 DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage Xiao, Xiao Liang, Jiankai Huang, Chunlong Li, Kai Xing, Fan Zhu, Wenbo Lin, Ziqing Xu, Wencang Wu, Guangen Zhang, Jifu Lin, Xi Tan, Yaqian Cai, Jing Hu, Jun Chen, Xueqin Huang, Youwei Qin, Zixi Qiu, Pengxin Su, Xingwen Chen, Lijun Lin, Yuan Zhang, Haipeng Yan, Guangmei Nat Commun Article Oncolytic virotherapy is a promising therapeutic strategy that uses replication-competent viruses to selectively destroy malignancies. However, the therapeutic effect of certain oncolytic viruses (OVs) varies among cancer patients. Thus, it is necessary to overcome resistance to OVs through rationally designed combination strategies. Here, through an anticancer drug screening, we show that DNA-dependent protein kinase (DNA-PK) inhibition sensitizes cancer cells to OV M1 and improves therapeutic effects in refractory cancer models in vivo and in patient tumour samples. Infection of M1 virus triggers the transcription of interferons (IFNs) and the activation of the antiviral response, which can be abolished by pretreatment of DNA-PK inhibitor (DNA-PKI), resulting in selectively enhanced replication of OV M1 within malignancies. Furthermore, DNA-PK inhibition promotes the DNA damage response induced by M1 virus, leading to increased tumour cell apoptosis. Together, our study identifies the combination of DNA-PKI and OV M1 as a potential treatment for cancers. Nature Publishing Group UK 2018-10-18 /pmc/articles/PMC6194050/ /pubmed/30337542 http://dx.doi.org/10.1038/s41467-018-06771-4 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Xiao, Xiao Liang, Jiankai Huang, Chunlong Li, Kai Xing, Fan Zhu, Wenbo Lin, Ziqing Xu, Wencang Wu, Guangen Zhang, Jifu Lin, Xi Tan, Yaqian Cai, Jing Hu, Jun Chen, Xueqin Huang, Youwei Qin, Zixi Qiu, Pengxin Su, Xingwen Chen, Lijun Lin, Yuan Zhang, Haipeng Yan, Guangmei DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage |
title | DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage |
title_full | DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage |
title_fullStr | DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage |
title_full_unstemmed | DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage |
title_short | DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage |
title_sort | dna-pk inhibition synergizes with oncolytic virus m1 by inhibiting antiviral response and potentiating dna damage |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194050/ https://www.ncbi.nlm.nih.gov/pubmed/30337542 http://dx.doi.org/10.1038/s41467-018-06771-4 |
work_keys_str_mv | AT xiaoxiao dnapkinhibitionsynergizeswithoncolyticvirusm1byinhibitingantiviralresponseandpotentiatingdnadamage AT liangjiankai dnapkinhibitionsynergizeswithoncolyticvirusm1byinhibitingantiviralresponseandpotentiatingdnadamage AT huangchunlong dnapkinhibitionsynergizeswithoncolyticvirusm1byinhibitingantiviralresponseandpotentiatingdnadamage AT likai dnapkinhibitionsynergizeswithoncolyticvirusm1byinhibitingantiviralresponseandpotentiatingdnadamage AT xingfan dnapkinhibitionsynergizeswithoncolyticvirusm1byinhibitingantiviralresponseandpotentiatingdnadamage AT zhuwenbo dnapkinhibitionsynergizeswithoncolyticvirusm1byinhibitingantiviralresponseandpotentiatingdnadamage AT linziqing dnapkinhibitionsynergizeswithoncolyticvirusm1byinhibitingantiviralresponseandpotentiatingdnadamage AT xuwencang dnapkinhibitionsynergizeswithoncolyticvirusm1byinhibitingantiviralresponseandpotentiatingdnadamage AT wuguangen dnapkinhibitionsynergizeswithoncolyticvirusm1byinhibitingantiviralresponseandpotentiatingdnadamage AT zhangjifu dnapkinhibitionsynergizeswithoncolyticvirusm1byinhibitingantiviralresponseandpotentiatingdnadamage AT linxi dnapkinhibitionsynergizeswithoncolyticvirusm1byinhibitingantiviralresponseandpotentiatingdnadamage AT tanyaqian dnapkinhibitionsynergizeswithoncolyticvirusm1byinhibitingantiviralresponseandpotentiatingdnadamage AT caijing dnapkinhibitionsynergizeswithoncolyticvirusm1byinhibitingantiviralresponseandpotentiatingdnadamage AT hujun dnapkinhibitionsynergizeswithoncolyticvirusm1byinhibitingantiviralresponseandpotentiatingdnadamage AT chenxueqin dnapkinhibitionsynergizeswithoncolyticvirusm1byinhibitingantiviralresponseandpotentiatingdnadamage AT huangyouwei dnapkinhibitionsynergizeswithoncolyticvirusm1byinhibitingantiviralresponseandpotentiatingdnadamage AT qinzixi dnapkinhibitionsynergizeswithoncolyticvirusm1byinhibitingantiviralresponseandpotentiatingdnadamage AT qiupengxin dnapkinhibitionsynergizeswithoncolyticvirusm1byinhibitingantiviralresponseandpotentiatingdnadamage AT suxingwen dnapkinhibitionsynergizeswithoncolyticvirusm1byinhibitingantiviralresponseandpotentiatingdnadamage AT chenlijun dnapkinhibitionsynergizeswithoncolyticvirusm1byinhibitingantiviralresponseandpotentiatingdnadamage AT linyuan dnapkinhibitionsynergizeswithoncolyticvirusm1byinhibitingantiviralresponseandpotentiatingdnadamage AT zhanghaipeng dnapkinhibitionsynergizeswithoncolyticvirusm1byinhibitingantiviralresponseandpotentiatingdnadamage AT yanguangmei dnapkinhibitionsynergizeswithoncolyticvirusm1byinhibitingantiviralresponseandpotentiatingdnadamage |